
Bioelectronica is a biotechnology company that accelerates antibody discovery through its innovative Hypercell platform and Ab Finder software. The Hypercell platform is a high-throughput cell analysis and sorting system that enables researchers to quickly analyze and sort cells secreting proteins of interest, significantly improving screening volume and reducing costs compared to traditional methods. Their AI-powered Ab Finder software simplifies bioinformatics, allowing for intuitive visualization of single-cell antibody sequences. With a focus on automation and efficiency, Bioelectronica positions itself as a leader in the biopharmaceutical industry, catering to researchers seeking rapid and cost-effective solutions for antibody discovery.

Bioelectronica is a biotechnology company that accelerates antibody discovery through its innovative Hypercell platform and Ab Finder software. The Hypercell platform is a high-throughput cell analysis and sorting system that enables researchers to quickly analyze and sort cells secreting proteins of interest, significantly improving screening volume and reducing costs compared to traditional methods. Their AI-powered Ab Finder software simplifies bioinformatics, allowing for intuitive visualization of single-cell antibody sequences. With a focus on automation and efficiency, Bioelectronica positions itself as a leader in the biopharmaceutical industry, catering to researchers seeking rapid and cost-effective solutions for antibody discovery.
What they do: High-throughput single-cell secretion analysis & sorting (Hypercell) and AI/NGS antibody discovery software (AbFinder/AbFinderAI)
Headquarters: Reno, Nevada
Founded: 2017
Notable funding: Series A announced Feb 8, 2021 (lead: Proxima Ventures Ltd)
Antibody discovery and single-cell secreted-protein screening
2017
Biotechnology
Series A announced Feb 8, 2021; investors include Proxima Ventures Ltd and Cowin/Cowin Venture; Dealroom records ~ $16M for Feb 2021 Series A.
“Proxima Ventures Ltd (lead), Cowin Venture, Rising Tide”